Canlyniadau Chwilio - Alexandre Le Vert

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix^® Tetra, a Seasonal Hemagglutinin-Based Vaccine gan Nicola Groth, Jacques Bruhwyler, Jessika Tourneur, Emilie Piat, Philippe Moris, Alexandre Le Vert, Florence Nicolas

Cael y testun llawn

OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy gan Judith Del Campo, Séverine Valsesia, Elsa Nikly, Roberto Ruiu, Antonella Iacoviello, Elena Quaglino, Federica Cavallo, Dalil Hannani, Emilie Boucher, Florence Nicolas, Alexandre Le Vert, Francesco Doro

Cael y testun llawn

Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults gan Bart Jacobs, Isabel Leroux-Roels, Jacques Bruhwyler, Nicola Groth, Gwenn Waerlop, Yorick Janssens, Jessika Tourneur, Fien De Boever, Azhar Alhatemi, Philippe Moris, Alexandre Le Vert, Geert Leroux-Roels, Florence Nicolas

Cael y testun llawn

OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model gan Charlotte Primard, Elodie Monchâtre-Leroy, Judith Del Campo, Séverine Valsesia, Elsa Nikly, Marion Chevandier, Franck Boué, Alexandre Servat, Marine Wasniewski, Evelyne Picard-Meyer, Thomas Courant, Nicolas Collin, Francisco J. Salguero, Alexandre Le Vert, Delphine Guyon-Gellin, Florence Nicolas

Cael y testun llawn